Want to see HK:2591 full AI Analyst Report?

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Financial Statements

0 Followers

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Financial Overview

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's market cap is currently HK$1.82B. The company's EPS TTM is HK$; its P/E ratio is -4.60; Guangzhou Innogen Pharmaceutical Group Co Ltd Class H is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22
Income Statement
Total Revenue	¥ 128.11M	¥ 0.00	¥ 0.00	¥ 0.00
Gross Profit	¥ 104.43M	¥ -17.28M	¥ -19.65M	¥ -19.08M
Operating Income	¥ -333.90M	¥ -189.36M	¥ -746.84M	¥ -327.45M
EBITDA	¥ -324.30M	¥ -156.89M	¥ -711.42M	¥ -308.37M
Net Income	¥ -332.53M	¥ -174.69M	¥ -733.38M	¥ -306.99M
Balance Sheet
Cash & Short-Term Investments	¥ 1.21B	¥ 796.88M	¥ 945.34M	¥ 501.37M
Total Assets	¥ 1.57B	¥ 934.80M	¥ 1.11B	¥ 668.71M
Total Debt	¥ 166.33M	¥ 9.90M	¥ 46.59M	¥ 50.31M
Net Debt	¥ -803.41M	¥ -516.64M	¥ -361.08M	¥ -74.95M
Total Liabilities	¥ 517.84M	¥ 138.33M	¥ 400.24M	¥ 135.23M
Stockholders' Equity	¥ 1.05B	¥ 796.47M	¥ 705.13M	¥ 533.48M
Cash Flow
Free Cash Flow	¥ -317.57M	¥ -166.95M	¥ -176.79M	¥ -226.17M
Operating Cash Flow	¥ -295.54M	¥ -162.62M	¥ -164.60M	¥ -197.33M
Investing Cash Flow	¥ 22.63M	¥ 275.95M	¥ -157.21M	¥ -77.24M
Financing Cash Flow	¥ 722.37M	¥ 254.84M	¥ 351.71M	¥ 9.95M

Currency in CNY

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Earnings and Revenue History

Income Statement >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Debt to Assets

Balance Sheet >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Cash Flow

Cash Flow >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Forecast EPS vs Actual EPS

Earnings >